Samsung Biologics Reports Third Quarter 2021 Financial Results |
| October 26, 2021 | October 2021 Bond Updates |
|
Q3'21 revenue of KRW 450.7 billion increased 64% compared to Q3'20. Q3'21 operating profit of KRW 167.4 billion increased 196% compared to Q3'20. Stable supply, strong operational excellence and a high utilization rate across all plants. Active investment on expansion, pre-sales... |
| View more at: https://www.prnewswire.com:443/news-releases/samsung-biologics-reports-third-quarter-2021-financial-results-301408352.html |
| Related News |
|